{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:36:03Z","timestamp":1789983363202,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.wneu.2020.07.165","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:44:40Z","timestamp":1596195880000},"page":"e391-e399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Somatostatin Receptor\u2013Targeted Radioligand Therapy in Head and Neck Paraganglioma"],"prefix":"10.1016","volume":"143","author":[{"given":"Wolfgang","family":"Roll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"M\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Sporns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Zinnhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-2105","authenticated-orcid":false,"given":"Eric","family":"Suero Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Weckesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Stegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim G.","family":"Beule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Stummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Rahbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2020.07.165_bib1","author":"Offergeld"},{"key":"10.1016\/j.wneu.2020.07.165_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.07.165_bib3","author":"Reubi"},{"key":"10.1016\/j.wneu.2020.07.165_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of 68Ga-DOTA\u2013conjugated somatostatin receptor\u2013targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis","volume":"60","author":"Han","year":"2019","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.wneu.2020.07.165_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","author":"Janssen","year":"2016","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.wneu.2020.07.165_bib6","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1210\/jc.2017-00816","article-title":"Efficacy of peptide receptor radionuclide therapy for functional metastatic paraganglioma and pheochromocytoma","volume":"102","author":"Kong","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2020.07.165_bib7","author":"van Essen"},{"key":"10.1016\/j.wneu.2020.07.165_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0032-1311637","article-title":"Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL)","volume":"44","author":"Zovato","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.wneu.2020.07.165_bib9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00259-015-3029-2","article-title":"Peptide receptor radionuclide therapy with 90Y\/177Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)","volume":"42","author":"Puranik","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.wneu.2020.07.165_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000499497","article-title":"Peptide receptor radionuclide therapy as a novel treatment for metastatic and invasive phaeochromocytoma and paraganglioma","volume":"109","author":"Mak","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.wneu.2020.07.165_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000360864","article-title":"A\u00a0retrospective analysis of tumor volumetric responses to five-fraction stereotactic radiotherapy for paragangliomas of the head and neck (glomus tumors)","volume":"92","author":"Chun","year":"2014","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.wneu.2020.07.165_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","article-title":"The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours","volume":"40","author":"Zaknun","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.wneu.2020.07.165_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.wneu.2020.07.165_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-017-2715-2","article-title":"Simpson grade IV resections of skull base meningiomas: does the postoperative tumor volume impact progression?","volume":"137","author":"Brokinkel","year":"2018","journal-title":"J\u00a0Neurooncol"},{"issue":"Suppl 1","key":"10.1016\/j.wneu.2020.07.165_bib15","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET Response Criteria in Solid Tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.wneu.2020.07.165_bib16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1053\/j.gastro.2017.11.008","article-title":"Prognostic utility of total 68Ga-DOTATATE-avid tumor volume in patients with neuroendocrine tumors","volume":"154","author":"Tirosh","year":"2018","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.wneu.2020.07.165_bib17","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/annonc\/10.suppl_2.S23","article-title":"Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy","volume":"10","author":"Krenning","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2020.07.165_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1148\/radiol.13122607","article-title":"Response assessment in pediatric rhabdomyosarcoma: can Response Evaluation Criteria in Solid Tumors replace three-dimensional volume assessments?","volume":"269","author":"Schoot","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.wneu.2020.07.165_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/neuonc\/noy137","article-title":"Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2020.07.165_bib20","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/cam4.2002","article-title":"The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing sarcoma","volume":"8","author":"Haveman","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.wneu.2020.07.165_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.wneu.2020.07.165_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13550-019-0484-y","article-title":"Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas","volume":"9","author":"Yadav","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.wneu.2020.07.165_bib23","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00330-005-2743-8","article-title":"Imaging and management of head and neck paragangliomas","volume":"15","author":"van den Berg","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1016\/j.wneu.2020.07.165_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.wneu.2020.07.165_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11307-014-0795-3","article-title":"SUV of [68Ga]DOTATOC-PET\/CT predicts response probability of PRRT in neuroendocrine tumors","volume":"17","author":"Kratochwil","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.wneu.2020.07.165_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2967\/jnumed.114.148437","article-title":"Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE","volume":"56","author":"Ilan","year":"2015","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.wneu.2020.07.165_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13139-015-0332-6","article-title":"The challenges of treating paraganglioma patients with 177Lu-DOTATATE PRRT: catecholamine crises, tumor lysis syndrome and the need for modification of treatment protocols","volume":"49","author":"Makis","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.wneu.2020.07.165_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.adro.2017.11.002","article-title":"External beam radiation therapy for advanced\/unresectable malignant paraganglioma and pheochromocytoma","volume":"3","author":"Breen","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.wneu.2020.07.165_bib29","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/hed.25664","article-title":"Radiotherapy for benign head and neck paragangliomas","volume":"41","author":"Mendenhall","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.wneu.2020.07.165_bib30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/coa.13116","article-title":"A\u00a0meta-analysis on the surgical management of paraganglioma of the carotid body per Shamblin class","volume":"43","author":"Jansen","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.wneu.2020.07.165_bib31","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1002\/cncr.28923","article-title":"Radiotherapy for benign head and neck paragangliomas: a 45-year experience","volume":"120","author":"Gilbo","year":"2014","journal-title":"Cancer"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020316879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020316879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:52:57Z","timestamp":1761814377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875020316879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":31,"alternative-id":["S1878875020316879"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2020.07.165","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatostatin Receptor\u2013Targeted Radioligand Therapy in Head and Neck Paraganglioma","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2020.07.165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}